SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-002902
Filing Date
2023-03-06
Accepted
2023-03-06 16:05:16
Documents
13
Period of Report
2023-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akya-20230306x8k.htm   iXBRL 8-K 43056
2 EX-99.1 akya-20230306xex99d1.htm EX-99.1 207003
  Complete submission text file 0001558370-23-002902.txt   387193

Data Files

Seq Description Document Type Size
3 EX-101.SCH akya-20230306.xsd EX-101.SCH 3043
4 EX-101.LAB akya-20230306_lab.xml EX-101.LAB 16579
5 EX-101.PRE akya-20230306_pre.xml EX-101.PRE 10455
7 EXTRACTED XBRL INSTANCE DOCUMENT akya-20230306x8k_htm.xml XML 4992
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 23708908
SIC: 3826 Laboratory Analytical Instruments